#USA #Barcelona #Cell Therapies #Veeva Quality Cloud #Oxford Biomedica

Oxford Biomedica and Veeva Quality Cloud Partnership

In a noteworthy development in the pharmaceutical manufacturing sector, Oxford Biomedica (OXB), a leading global contract development and manufacturing organization (CDMO), has partnered with Veeva Systems to enhance its quality transformation efforts. The collaboration, announced in Barcelona on September 23, 2026, aims to implement Veeva Quality Cloud, a comprehensive solution designed to unify and streamline quality operations across Oxford Biomedica’s facilities in the UK, France, and the United States.

Significance of Quality Transformation

As a key player in advanced cell and gene therapies, Oxford Biomedica recognizes the critical need for robust quality management systems. In a statement made by Melanie Kearney, Senior Vice President and Head of Global Quality at OXB, she emphasized that adopting a modern quality platform is integral to creating consistent and efficient operational methods across their global network. By implementing Veeva Quality Cloud as its global Quality Management System (QMS), the company aims to standardize processes, bolster collaboration across its sites, and facilitate continuous improvement within the organization.

The commitment to high-quality standards ensures that clients partnering with Oxford Biomedica can trust in the governance and control of their processes, no matter the location of the facility.

Features of Veeva Quality Cloud

Veeva Quality Cloud is equipped with several tools that are streamlining various aspects of the manufacturing quality process:

• - Veeva QualityDocs: This tool supports controlled documentation, ensuring that all relevant materials and compliance documents are maintained efficiently.
• - Veeva QMS: A cornerstone of the quality platform, it provides a standardized approach to quality processes, helping to create uniformity across multiple sites.
• - Veeva Training and Veeva Learn GxP: These systems are designed to enhance training efficiency across the organization, ensuring that all personnel are equipped with up-to-date knowledge and skills necessary for compliance with Good Practice (GxP) guidelines.

Consolidating various quality management systems onto a singular cloud platform allows Oxford Biomedica to proactively meet the dynamic requirements of clients and regulatory bodies. The reduction of manual tasks also simplifies the technological landscape for their teams, allowing them to focus on more strategic aspects of their work.

A Focus on Patient Impact

Veeva’s Senior Strategy Director, Rob Weisz, highlighted the pivotal role of Oxford Biomedica’s commitment to quality and innovation in the delivery of life-changing therapies to patients worldwide. Veeva Quality Cloud establishes a technology framework that supports the expansion of quality operations across different geographies while maintaining the rigorous standards necessary for manufacturing.

“Quality operations must not only be efficient but also adaptable to the evolving landscape of the biopharmaceutical industry,” Weisz noted. The unification of quality processes through Veeva Quality Cloud not only enhances compliance but significantly reduces cycle times, thereby maximizing efficiency and improving service delivery.

Conclusion

In summary, the partnership between Oxford Biomedica and Veeva Systems signifies a transformative step for quality management in the biopharmaceutical industry. By leveraging advanced technological solutions, OXB is poised to enhance its manufacturing capabilities, ultimately benefiting patients who rely on their cutting-edge therapies. The implementation of Veeva Quality Cloud stands as a testament to Oxford Biomedica’s ongoing commitment to excellence in the realm of healthcare solutions.

For those interested in learning more about how Veeva Quality Cloud can aid CDMOs, further information is available at Veeva's official site.